The Role of Glutamate Transporters in the Pathophysiology of Neuropsychiatric Disorders

Overview

Journal NPJ Schizophr

Date 2017 Sep 23

PMID 28935880

Citations 75

Authors

Sinead M ODonovan

Courtney R Sullivan

Robert E McCullumsmith

Affiliations

Soon will be listed here.

Abstract

Altered glutamate transporter expression is a common feature of many neuropsychiatric conditions, including schizophrenia. Excitatory amino acid transporters (EAATs) are responsible for the reuptake of glutamate, preventing non-physiological spillover from the synapse. Postmortem studies have revealed significant dysregulation of EAAT expression in various brain regions at the cellular and subcellular level. Recent animal studies have also demonstrated a role for glutamate spillover as a mechanism of disease. In this review, we describe current evidence for the role of glutamate transporters in regulating synaptic plasticity and transmission. In neuropsychiatric conditions, EAAT splice variant expression is altered. There are changes in the localization of the transporters and disruption of the metabolic and structural protein network that supports EAAT activity. This results in aberrant neuroplasticity and excitatory signaling, contributing to the symptoms associated with neuropsychiatric disease. Understanding the complex functions of glutamate transporters will clarify the relevance of their role in the pathophysiology of neuropsychiatric disorders.

Citing Articles

Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer's Disease, a Potential Therapeutic Target.

Puranik N, Song M Molecules. 2024; 29(23).

PMID: 39683904 PMC: 11643865. DOI: 10.3390/molecules29235744.

Inhibitory Potential of the Truncated Isoforms on Glutamate Transporter Oligomerization Identified by Computational Analysis of Gene-Centric Isoform Maps.

Karagol A, Karagol T, Li M, Zhang S Pharm Res. 2024; 41(11):2173-2187.

PMID: 39487385 PMC: 11599315. DOI: 10.1007/s11095-024-03786-z.

Palmitic Acid Induces Oxidative Stress and Senescence in Human Brainstem Astrocytes, Downregulating Glutamate Reuptake Transporters-Implications for Obesity-Related Sympathoexcitation.

Sivasubramanian M, Monteiro R, Jagadeesh M, Balasubramanian P, Subramanian M Nutrients. 2024; 16(17).

PMID: 39275168 PMC: 11397225. DOI: 10.3390/nu16172852.

Ceftriaxone Inhibits Conditioned Fear and Compulsive-like Repetitive Marble Digging without Central Nervous System Side Effects Typical of Diazepam-A Study on DBA2/J Mice and a High-5HT Subline of Wistar-Zagreb 5HT Rats.

Poljak L, Mise B, cicin-Sain L, Tvrdeic A Biomedicines. 2024; 12(8).

PMID: 39200176 PMC: 11351474. DOI: 10.3390/biomedicines12081711.

Neuroinflammation and Neurometabolomic Profiling in Fentanyl Overdose Mouse Model Treated with Novel β-Lactam, MC-100093, and Ceftriaxone.

Alasmari M, Alasmari F, AlSharari S, Alasmari A, Ali N, Ahamad S Toxics. 2024; 12(8).

PMID: 39195706 PMC: 11360732. DOI: 10.3390/toxics12080604.

References

Rauen T, Wiessner M, Sullivan R, Lee A, Pow D . A new GLT1 splice variant: cloning and immunolocalization of GLT1c in the mammalian retina and brain. Neurochem Int. 2004; 45(7):1095-106. DOI: 10.1016/j.neuint.2004.04.006. View

Haydon P, Carmignoto G . Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev. 2006; 86(3):1009-31. DOI: 10.1152/physrev.00049.2005. View

Lynch R, Balaban R . Coupling of aerobic glycolysis and Na+-K+-ATPase in renal cell line MDCK. Am J Physiol. 1987; 253(2 Pt 1):C269-76. DOI: 10.1152/ajpcell.1987.253.2.C269. View

Cross A, Slater P, Reynolds G . Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease. Neurosci Lett. 1986; 67(2):198-202. DOI: 10.1016/0304-3940(86)90397-6. View

Dere E, De Souza-Silva M, Frisch C, Teubner B, Sohl G, Willecke K . Connexin30-deficient mice show increased emotionality and decreased rearing activity in the open-field along with neurochemical changes. Eur J Neurosci. 2003; 18(3):629-38. DOI: 10.1046/j.1460-9568.2003.02784.x. View

Malenka R, Bear M . LTP and LTD: an embarrassment of riches. Neuron. 2004; 44(1):5-21. DOI: 10.1016/j.neuron.2004.09.012. View

Flomen R, Makoff A . Increased RNA editing in EAAT2 pre-mRNA from amyotrophic lateral sclerosis patients: involvement of a cryptic polyadenylation site. Neurosci Lett. 2011; 497(2):139-43. DOI: 10.1016/j.neulet.2011.04.047. View

Meyer T, Munch C, Volkel H, Booms P, Ludolph A . The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry. 1998; 65(4):594-6. PMC: 2170294. DOI: 10.1136/jnnp.65.4.594. View

Jackson J, ODonnell J, Krizman E, Robinson M . Displacing hexokinase from mitochondrial voltage-dependent anion channel impairs GLT-1-mediated glutamate uptake but does not disrupt interactions between GLT-1 and mitochondrial proteins. J Neurosci Res. 2014; 93(7):999-1008. PMC: 4441544. DOI: 10.1002/jnr.23533. View

10.

Zerangue N, Kavanaugh M . Flux coupling in a neuronal glutamate transporter. Nature. 1996; 383(6601):634-7. DOI: 10.1038/383634a0. View

11.

Sogaard R, Borre L, Braunstein T, Madsen K, MacAulay N . Functional modulation of the glutamate transporter variant GLT1b by the PDZ domain protein PICK1. J Biol Chem. 2013; 288(28):20195-207. PMC: 3711287. DOI: 10.1074/jbc.M113.471128. View

12.

Turrigiano G . Homeostatic signaling: the positive side of negative feedback. Curr Opin Neurobiol. 2007; 17(3):318-24. DOI: 10.1016/j.conb.2007.04.004. View

13.

Rothstein J, van Kammen M, Levey A, Martin L, Kuncl R . Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 1995; 38(1):73-84. DOI: 10.1002/ana.410380114. View

14.

Furness D, Dehnes Y, Akhtar A, Rossi D, Hamann M, Grutle N . A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2). Neuroscience. 2008; 157(1):80-94. PMC: 2775085. DOI: 10.1016/j.neuroscience.2008.08.043. View

15.

Marx M, Billups D, Billups B . Maintaining the presynaptic glutamate supply for excitatory neurotransmission. J Neurosci Res. 2015; 93(7):1031-44. DOI: 10.1002/jnr.23561. View

16.

Maragakis N, Dykes-Hoberg M, Rothstein J . Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann Neurol. 2004; 55(4):469-77. DOI: 10.1002/ana.20003. View

17.

Davies P, Maloney A . Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 1976; 2(8000):1403. DOI: 10.1016/s0140-6736(76)91936-x. View

18.

Li L, Toan S, Zelenaia O, Watson D, Wolfe J, Rothstein J . Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J Neurochem. 2006; 97(3):759-71. DOI: 10.1111/j.1471-4159.2006.03743.x. View

19.

Seal R, Amara S . A reentrant loop domain in the glutamate carrier EAAT1 participates in substrate binding and translocation. Neuron. 1999; 21(6):1487-98. DOI: 10.1016/s0896-6273(00)80666-2. View

20.

Shan D, Lucas E, Drummond J, Haroutunian V, Meador-Woodruff J, McCullumsmith R . Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia. Schizophr Res. 2013; 144(1-3):1-8. PMC: 3572263. DOI: 10.1016/j.schres.2012.12.019. View